跳至主要内容
临床试验/NCT02823041
NCT02823041已完成不适用

Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode

University of California, Los Angeles2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2016年10月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) overall composite score

研究概览

简要总结

This is a confirmatory randomized controlled trial of the efficacy of a novel intervention combining neuroplasticity-based cognitive training with aerobic exercise, compared to the same systematic cognitive training alone. Treatment occurs for 6 months after randomization, with a followup assessment at 12 months. The investigators hypothesize that combining neuroplasticity-based computerized cognitive training and neurotrophin-enhancing physical exercise will produce neurotrophin increases and cognitive and functional improvements, even relative to cognitive training alone. The investigators target the period shortly after a first episode of schizophrenia to maximize the generalization of cognitive improvement to functional outcome, before chronic disability is established.

详细描述

The Cognitive Training and Exercise intervention consists of 24 weeks of systematic computerized cognitive training, 4 hours per week, plus aerobic exercise, 150 minutes per week. The Cognitive Training Intervention includes the same systematic cognitive training. The first 12 weeks involve neurocognitive training, using training exercises from Posit Science Brain HQ. The second 12 weeks involves social cognitive training, using the Posit Science SocialVille modules. Aerobic exercise occurs as two 45-minute sessions at the clinic and two 30-minute sessions at home weekly. Intensity of aerobic exercise is tailored to maintain an individualized target heart rate zone and is monitored by a heart rate recorder. A weekly one-hour Bridging Skills Group with other members of the treatment condition is designed to aid generalization of training to everyday life situations. The immediate target is brain-derived neurotrophic factor. The primary treatment outcomes are overall cognitive deficit level and global functioning level.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • a first episode of a psychotic illness that began within the past two years;
  • a diagnosis by DSM-5 of schizophrenia, schizoaffective disorder, mainly depressed type, or schizophreniform disorder;
  • sufficient acculturation and fluency in the English language to avoid invalidating research measures; and
  • residence likely to be within commuting distance of the UCLA Aftercare Research Program.

排除标准

  • inability to participate in aerobic exercise;
  • evidence of a known neurological disorder (e.g., epilepsy) or significant head injury;
  • evidence of moderate or severe alcohol or substance use disorder within the six months prior to the first episode or evidence that substance abuse triggered the psychotic episode or makes the schizophrenia diagnosis ambiguous; or
  • mental retardation, i.e. estimated premorbid IQ less than 70.

结局指标

主要结局

Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) overall composite score

时间窗: 6 months

The Overall Composite score from the MCCB is a summary of cognitive performance across seven domains.

Brain-derived neurotrophic factor (BDNF)

时间窗: 6 months

BDNF is a key neurochemical factor known to mediate the effects of exercise in the brain

Global Functioning Scale: mean of Role and Social ratings

时间窗: 6 months

A 10-point rating scale to evaluate role and social functioning

次要结局

  • YMCA fitness test(6 months)
  • Role Functioning Scale(6 months)
  • VO2 Max(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Keith Nuechterlein, Ph.D.

Principal Investigator

University of California, Los Angeles

研究点 (2)

Loading locations...

相似试验